| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |